Mylan Inc. - MYL - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: June 16, 2013

Mylan Inc. - SIC # 2834

Ticker	Exchange	SIC #	Website	Latest Ticker
MYL	Nasdaq	2834	http://www.mylan.com/	31.87 +0.33
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Mylan Inc. InPlay: Mylan Labs announces pricing of senior notes - Jun 18th, 2013 2:21 pm Mylan Announces Pricing of Senior Notes - Jun 18th, 2013 2:18 pm Company Credit Swaps in U.S. Hold as Fed Starts Two-Day Meeting - Jun 18th, 2013 11:23 am MYLAN INC. Files SEC form 8-K, Other Events - Jun 18th, 2013 8:31 am Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign - Jun 18th, 2013 5:00 am Simcere Ties Up with Bristol-Myers - Jun 17th, 2013 3:20 pm Label Expansion for Astellas Drug - Jun 17th, 2013 2:50 pm Supreme Court rules generic drug makers can be sued over 'pay to delay' - Jun 17th, 2013 11:20 am Merck, Pfizer Sue Mylan to Block Proposed Copy of AzaSite - Jun 17th, 2013 10:38 am Warner Chilcott: Should You Buy Joel Greenblatt's Latest Pick? - Jun 14th, 2013 9:34 am Is This Hurting Healthcare Company Priced for a Recovery? - Jun 14th, 2013 6:54 am $2.15B Settlement for Pfizer's Protonix - Jun 13th, 2013 3:40 pm Undervalued Teva Must Enter New Markets - Jun 12th, 2013 5:56 pm Mylan, Inc. Presents at Goldman Sachs 34th Annual Global Healthcare Conference, Jun-12-2013 10:00 AM - Jun 12th, 2013 5:00 pm 5 Leading Women in Health Care - Jun 12th, 2013 12:09 pm Mylan to Speak at the Goldman Sachs 34th Annual Global Healthcare Conference - Jun 12th, 2013 8:51 am Mylan to Speak at the Goldman Sachs 34th Annual Global Healthcare Conference - Jun 12th, 2013 7:02 am Which Generic Drugmaker Is Your Best Buy Today? - Jun 6th, 2013 2:14 pm EU to fine Ranbaxy, others for blocking generic drugs - Jun 3rd, 2013 9:50 am Exclusive - EU to fine Lundbeck, others for blocking generic drugs - Jun 3rd, 2013 9:27 am View All Current Headlines >>